SCHEMBL3606864

SCHEMBL3606864

COc1ccc(C(=O)/C=C/N(C)C)cc1F

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.76
LMNA P02545 4/20 0.76
ALDH1A1 P00352 6/20 0.59
HPGD P15428 4/20 0.59
RAB9A P51151 4/20 0.58
HTT P42858 3/20 0.58
CYP1A2 P05177 2/20 0.58
CYP2C19 P33261 2/20 0.58
MAPK1 P28482 1/20 0.58
TUBB1 Q9H4B7 1/20 0.51
RECQL P46063 2/20 0.50
ALOX12 P18054 1/20 0.50
ABCG2 Q9UNQ0 2/20 0.49
GAA P10253 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
ACHE P22303 1/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
POLB P06746 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3606868 1.00 MAPT (0.76) MAPTLMNAALDH1A1HPGDRAB9A
SCHEMBL24370978 0.88 MAPT (0.76) MAPTLMNAALDH1A1HPGDRAB9A
SCHEMBL783250 0.86 MAPT (1.00) MAPTLMNAALDH1A1HPGDRAB9A
SCHEMBL805341 0.86 MAPT (1.00) MAPTLMNAALDH1A1HPGDRAB9A
SCHEMBL16911749 0.84 MAPT (0.78) MAPTLMNAALDH1A1HPGDRAB9A
SCHEMBL16627905 0.84 MAPT (0.78) MAPTLMNAALDH1A1HPGDRAB9A
SCHEMBL2837468 0.83 CYP1A2 (0.67) MAPTLMNAALDH1A1HPGDRAB9A
SCHEMBL15777509 0.83 CYP1A2 (0.67) MAPTLMNAALDH1A1HPGDRAB9A
SCHEMBL3610221 0.82 MAPT (0.76) MAPTLMNAALDH1A1HPGDRAB9A
SCHEMBL16628019 0.82 MAPT (0.76) MAPTLMNAALDH1A1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7723348-B2 Phosphodiesterase 4 inhibitors MEMORY PHARMACEUTICALS CORPORATION (US) 2010-05-25 US disclosed
US-7432266-B2 Phosphodiesterase 4 inhibitors MEMORY PHARMACEUTICALS CORPORATION (US) 2008-10-07 US disclosed
US-20080207660-A1 PHOSPHODIESTERASE 4 INHIBITORS HOPPER ALLEN 2008-08-28 US disclosed
WO-2007123953-A2 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2007-11-01 WO disclosed
US-20070254913-A1 Phosphodiesterase 4 inhibitors MEMORY PHARMACEUTICALS CORPORATION 2007-11-01 US disclosed
EP-1799673-A1 PYRAZOLE DERIVATIVES AS PHOSPHODIESTERASE 4 INHIBITORS Memory Pharmaceuticals Corporation (US) 2007-06-27 EP disclosed
US-20060154960-A1 Phosphodiesterase 4 inhibitors MEMORY PHARMACEUTICALS CORPORATION 2006-07-13 US disclosed
WO-2006044528-A1 PYRAZOLE DERIVATIVES AS PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2006-04-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254913-A1 Phosphodiesterase 4 inhibitors PDE4A, PDE4B, PDE12 MAPT 3815/4885LMNA 3738/4885ALDH1A1 515/4885
US-20080207660-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE12 MAPT 3815/4885LMNA 3738/4885ALDH1A1 515/4885
US-20060154960-A1 Phosphodiesterase 4 inhibitors PDE4A, PDE4B, PDE12 MAPT 3815/4885LMNA 3738/4885ALDH1A1 515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.